Menu

StemExpress Announces Release of New Frozen Leukopak® to Advance Research

To continue to provide new products and services to further advance medical research around the world, today, StemExpress announced the release of their Frozen Leukopak®.

Jun 7, 2019
StemExpress

StemExpress Leukopaks®, collected fresh and then immediately frozen, provide an enriched source of peripheral blood mononuclear cells (PBMCs) that can be used in a variety of medical research areas such as cancer, autoimmune diseases, device development and more.  

“Although we are widely known for same-day delivery of fresh biospecimen products from one of our multiple collection sites, we understand that the need for frozen products can be very beneficial to both our US-based and international partners,” said Matt Phillips, vice president of sales and marketing. 

 Shipping of fresh biospecimen products over long distances can be stressful on cells and compromise their quality. The new format, frozen directly after donor collection, will provide high-quality cells with increased flexibility of use. 

Additionally, this new format can be customized per client request. For example, one Leukopak® can be split, frozen and shipped to multiple laboratories involved in the same study or to compare laboratory staff competencies, equipment functionality, data analysis and reporting.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.